US 12,226,395 B2
Composition for preventing or treating neurodegenerative diseases, containing diterpene-based compound
Won Gon Kim, Daejeon (KR); Baek Soo Han, Daejeon (KR); Jeong Su Byun, Daejeon (KR); Van Minh Nguyen, Daejeon (KR); and Ha Young Choi, Daejeon (KR)
Assigned to KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, Daejeon (KR)
Filed by KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, Daejeon (KR)
Filed on Jul. 8, 2022, as Appl. No. 17/811,327.
Application 17/811,327 is a division of application No. 16/763,630, abandoned, previously published as PCT/KR2018/013990, filed on Nov. 15, 2018.
Claims priority of application No. 10-2017-0152487 (KR), filed on Nov. 15, 2017; and application No. 10-2017-0153861 (KR), filed on Nov. 15, 2017.
Prior Publication US 2022/0370407 A1, Nov. 24, 2022
Int. Cl. A61K 31/36 (2006.01); A23L 33/105 (2016.01); A61K 31/232 (2006.01)
CPC A61K 31/36 (2013.01) [A23L 33/105 (2016.08); A61K 31/232 (2013.01)] 5 Claims
OG exemplary drawing
 
1. A method of treating a neurodegenerative disease comprising administering a pharmaceutical composition consisting of a pharmaceutically effective amount of one and only one isolated diterpene selected from the group consisting of Formulas 1 to 10, or a pharmaceutically acceptable salt thereof as an active ingredient and a pharmaceutically acceptable carrier, optionally with conventional therapeutic agents for treating neurodegenerative diseases to a subject in need thereof, wherein the composition excludes an extract of Daphne genkwa:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry